SpyGlass Pharma SGP
NASDAQ SGP
$27.32 +1.16 (+4.43%)
As of: Oct 21, 2026 · 3:35 PM EDT

SpyGlass Pharma (SGP) Market Capitalization (2026)

Updated

SpyGlass Pharma (SGP) posted Market Capitalization of $744.51 million for Q2 2026.

Analysis

SpyGlass Pharma (SGP) Market Capitalization (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn
10 SpyGlass Pharma 915.74 Mn 915.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 744.51 Mn
API Access

SpyGlass Pharma Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=SGP&period=max&api_key=YOUR_API_KEY